Arterys Partners with Combinostics for Neurodegenerative Disease and MS Evaluations

AI medical imaging platform Arterys partnered with Combinostics to make their AI imaging solution, cNeuro® available on the Arterys Platform. The partnership enables Arterys to have the most comprehensive Neuro AI suite on the market covering a broad set of applications in neuroradiology, the company said.

Arterys has initially fully integrated the cMRI™ algorithms from the cNeuro suite and they will be available via its FDA-cleared and CE marked MICA platform to its installed base in the coming weeks. The platform’s cloud SaaS model enables the cMRI™ workflow-enhancing algorithms to be delivered instantly to any of Arterys’ existing customers. Read more.

Total
0
Shares
Related Posts